Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
1501
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.92M | ﹤0.01% |
46,900
+1,200
| +3% | +$57K |
|
|
INST
1502
DELISTED
Instructure, Inc.
INST
| $2.91M | ﹤0.01% |
60,400
+2,100
| +4% | +$98.5K |
|
|
TWOU
1503
DELISTED
2U Inc
TWOU
| $2.91M | ﹤0.01% |
4,043
+390
| +11% | +$243K |
|
1504
S&T Bancorp
STBA
$1.82B
| $2.91M | ﹤0.01% |
72,200
+1,600
| +2% | +$60.6K |
|
|
AQUA
1505
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.9M | ﹤0.01% |
153,300
+3,100
| +2% | +$55.6K |
|
|
CVGW
1506
DELISTED
Calavo Growers
CVGW
| $2.9M | ﹤0.01% |
32,000
+500
| +2% | +$44.7K |
|
1507
Park National Corp
PRK
$3.72B
| $2.9M | ﹤0.01% |
28,300
+200
| +0.7% | +$20K |
|
|
PRFT
1508
DELISTED
Perficient Inc
PRFT
| $2.89M | ﹤0.01% |
62,800
+1,200
| +2% | +$48.9K |
|
1509
TTM Technologies
TTMI
$14.6B
| $2.89M | ﹤0.01% |
191,900
+4,000
| +2% | +$52.6K |
|
1510
AAR Corp
AIR
$5.96B
| $2.87M | ﹤0.01% |
63,700
+1,200
| +2% | +$52.1K |
|
|
NGHC
1511
DELISTED
National General Holdings Corp
NGHC
| $2.87M | ﹤0.01% |
130,022
+2,600
| +2% | +$56.8K |
|
|
TSE
1512
DELISTED
Trinseo
TSE
| $2.87M | ﹤0.01% |
77,100
| – | – |
|
|
AVYA
1513
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.87M | ﹤0.01% |
212,500
+4,600
| +2% | +$56.5K |
|
|
ODP
1514
DELISTED
ODP
ODP
| $2.87M | ﹤0.01% |
104,600
+2,100
| +2% | +$46.7K |
|
|
EGOV
1515
DELISTED
NIC Inc
EGOV
| $2.87M | ﹤0.01% |
128,200
+2,700
| +2% | +$59.1K |
|
|
CCXI
1516
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.86M | ﹤0.01% |
72,400
+18,000
| +33% | +$316K |
|
|
FIT
1517
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.86M | ﹤0.01% |
434,700
+14,800
| +4% | +$86.8K |
|
|
KEM
1518
DELISTED
KEMET Corporation
KEM
| $2.85M | ﹤0.01% |
105,500
+2,300
| +2% | +$55.9K |
|
1519
Dycom Industries
DY
$12.3B
| $2.84M | ﹤0.01% |
60,300
+1,300
| +2% | +$63.3K |
|
|
GCP
1520
DELISTED
GCP Applied Technologies Inc.
GCP
| $2.84M | ﹤0.01% |
125,200
+2,300
| +2% | +$49.5K |
|
1521
Cohen & Steers
CNS
$4.36B
| $2.84M | ﹤0.01% |
45,200
+1,000
| +2% | +$63.3K |
|
1522
Magnolia Oil & Gas
MGY
$6.25B
| $2.84M | ﹤0.01% |
225,400
+21,800
| +11% | +$244K |
|
1523
Oceaneering
OII
$5.08B
| $2.82M | ﹤0.01% |
189,348
+3,300
| +2% | +$45.9K |
|
1524
OceanFirst Financial
OCFC
$1.85B
| $2.81M | ﹤0.01% |
110,033
+13,800
| +14% | +$332K |
|
1525
Gentherm
THRM
$1.27B
| $2.81M | ﹤0.01% |
63,300
| – | – |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.